| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |